---
title: "OSI | 8-K: FY2026 Revenue Misses Estimate at USD 1.786 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296530822.md"
datetime: "2026-08-20T20:05:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296530822.md)
  - [en](https://longbridge.com/en/news/296530822.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296530822.md)
generator: "portal-rs"
---

# OSI | 8-K: FY2026 Revenue Misses Estimate at USD 1.786 B

Revenue: As of FY2026, the actual value is USD 1.786 B, missing the estimate of USD 1.832 B.

EPS: As of FY2026, the actual value is USD 8.95, missing the estimate of USD 9.242.

EBIT: As of FY2026, the actual value is USD 218.97 M.

#### Share Repurchase Program

On August 20, 2026, the Board of Directors of OSI Systems, Inc. approved an additional 1,000,000 shares for repurchase under its stock repurchase program, which increased the total remaining authorization for share repurchases to 1,078,731 shares .

#### Share Repurchases

During the quarter ended June 30, 2026, OSI Systems, Inc. repurchased 564,880 shares of its common stock .

#### Outlook

The expanded share repurchase authorization reflects OSI Systems, Inc.’s continued confidence in its long-term strategy and strong free cash flow generation . The company views this action as a way to execute capital allocation priorities by returning capital to shareholders . This strategy also allows for maintaining flexibility to invest in growth opportunities .

### Related Stocks

- [OSIS.US](https://longbridge.com/en/quote/OSIS.US.md)

## Related News & Research

- [OSI Systems (OSIS) Reports Higher Earnings, Is It Still Below Fair Value?](https://longbridge.com/en/news/297940315.md)
- [OSIS SHAREHOLDER ALERT: OSI Systems, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations](https://longbridge.com/en/news/298377805.md)
- [Weekly Recap: 1.5M-share inducement grant and furnished Form 8-K PSU award](https://longbridge.com/en/news/298207980.md)
- [Bukit Asam holds BIGMIND Innovation Award 2026 roadshow in Tanjung Enim](https://longbridge.com/en/news/298424176.md)
- [Vivos Therapeutics amends 8-K to correct report date to Sept. 2, 2026](https://longbridge.com/en/news/298368513.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**